Sabra Health Care REIT, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $774.6M | $703.2M | $647.5M | $624.8M | $569.5M |
| Cash from operations | $348.6M | $310.5M | $300.6M | $315.7M | $356.4M |
| Capital expenditure | $41.5M | $54.7M | $84.9M | $54.5M | $42.7M |
| Free cash flow | $307.1M | $255.8M | $215.7M | $261.3M | $313.7M |
| Total assets | $5.5B | $5.3B | $5.4B | $5.7B | $6.0B |
| Total liabilities | $2.7B | $2.6B | $2.6B | $2.7B | $2.6B |
| Total debt | $2.6B | $2.4B | $2.4B | $2.5B | $2.4B |
Shares outstanding 252.2M · Free float 98.6%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.